Anxiety State, Esketamine
Conditions
Keywords
esketamine, anxiety state
Brief summary
To evaluate whether esketamine can relieve anxiety in patients undergoing abdominal tumor surgery.
Detailed description
Hamilton anxiety Scale was used to screen patients with anxiety. Only patients with score ≥ 8 were enrolled. These patients were randomly assigned to the experimental group and control group. All patients enrolled were evaluated with Hamilton anxiety Scale, PHQ-8 scale, QoR-15 Scale and Athens Insomnia Scale. After induction, sevoflurane and remifentanil were used to maintain anesthesia. The experimental group had esketamine while the control group had normal saline. Athens Insomnia Scale was used to assess the sleep status 1, 2, 3 days after surgery and 1 month after surgery. Hamilton anxiety Scale was used to evaluate the anxiety state of the patients 3 days after surgery and 1 month after surgery. PHQ-8 scale, QoR-15 Scale were collected 3 days after surgery and 1 month after surgery.
Interventions
DRUGEsketamine
Esketamine 0.2mg/kg was pumped slowly after intubation, followed by 0.1mg/kg pumped until the end of the operation. In the PCIA pump, esketamine 1mg/kg was added to the sufentanil.
DRUGnormal saline
Same volume of normal saline was pumped slowly after intubation, followed by the same volume of NS until the end of the operation. In the PCIA pump, only sufentanil was used.
Sponsors
Zhejiang Cancer Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Patients undergoing abdominal tumor surgery; * older than 18 years old and younger than 70 years old; * ASA grade I-III； * Hamilton anxiety scale ≥ 8.
Exclusion criteria
* Having serious mental illness before surgery or on antipsychotic medication in the two weeks before screening; * Severe organ function lesions such as heart failure (left ventricular ejection fraction \<30%), myocardial infarction, kidney failure (requiring kidney replacement therapy), liver function impairment (Child-Pugh grade C), etc. * Patients arranged to receive general anesthesia combined with epidural anesthesia patients; * Patients who cannot communicate, read or write due to visual, auditory, language or other reasons; * Patients allergic to ketamine; * Patients refused to use postoperative self-controlled intravenous analgesia pump; * Patients refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Whether esketamine can reduce anxiety status in patients with anxiety | 1 day before surgery, 3 days after surgery, 1 month after surgery | assessed by Hamilton anxiety scale. The score ranges from 0 to 56, while the higher score means a more anxious state. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To explore whether esketamine can improve sleep status | 1 day before surgery, 1,2 and 3 days after surgery, 1 month after surgery | assessed by Athens Insomnia Scale. Athens Insomnia Scale ranges from o to 24, with a higher score means a worse sleep status. |
| To explore whether esketamine can improve life quality | 1 day before surgery, 3 days after surgery, 1 month after surgery | assessed by QoR-15 (quality of recovery-15). The score ranges from 0 (bad quality) to 150 (good quality). |
Countries
China
Outcome results
None listed